Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Final Astroworld suit settled
At least 100 killed in landslide
'This means war'
US issues visa restrictions
Drops ‘Dark Times' album
Official images of B21 Raider
Duggan can be extradited
Bong's plane discovered?
2022 Osprey crash lawsuit
Arrested, charged w/ fraud
First teaser revealed
US service members injured
Approves ETFs for Ether
Support AIDS research
Pistons new president?
OH gov. calls special session
ISR Rafah offensive ruling
Gets Walk of Fame star
2 shot at graduation event
To hold output policy meeting
Priest bites woman?
Daytime Emmy Awards hosts
Wins Idaho caucuses
Judge revisits immigration law
'Doge' meme dog dies
Ala. coal ash plan rejected
China's 2nd day of war games
Planet that could support life
Lucid to cut workforce by 6%
AI deals with Hollywood?
CIA director to visit Europe
Lovett joins ‘Survivor’ cast
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax, Sanofi
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot.
Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline
Sanofi on Friday said it had reached a deal worth up to $1.2 billion to sell Novavax’s Covid shot as well as to try to combine the vaccine with its own flu shot.
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to $1.4 billion with Sanofi (SNY, FR:SAN). Novavax sha
Benefits Pro
11d
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
With flu and COVID hospital admission rates now mirroring each other,
Novavax
, which lost out in the COVID
vaccine
race ...
4d
on MSN
Shah Capital ends campaign against Novavax board after Sanofi deal
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback